Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels (Q33603319)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels |
scientific article |
Statements
1 reference
Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels (English)
1 reference
1 reference
glycated hemoglobin
23 October 2023
Masahiro Iwasaki
1 reference
Fuminori Hoshian
1 reference
Tomoko Tsuji
1 reference
Naoki Hirose
1 reference
Tomoko Matsumoto
1 reference
Naomi Kitatani
1 reference
Kenji Sugawara
1 reference
Hitoshi Kuwata
1 reference
Kazu Sugizaki
1 reference
Yuka Kitamoto
1 reference
Shuichi Fujiwara
1 reference
Koin Watanabe
1 reference
Takanori Hyo
1 reference
Takeshi Kurose
1 reference
Yutaka Seino
1 reference
1 October 2012
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference